Ann: FRG Trials on Tuberculosis, page-258

From my memory has it not been stated at the AGM that they are in negotiations and testing with OEM's?  And that one issue that was being considered is that they didn't want to give exclusive rights to the tech (unless its a massive deal perhaps)?  Perhaps those names were mentioned because they contain the names which they are already talking to, and more than that, negotiating with.   I assume, given how amazing this tech seems, that it would be in the best interests of OEM's to get it to market as quick as possible also, lest their competitor do it first.  In fact the exclusive deal can be used as leverage to push for better deals.....  My thinking is along you lines Smitty.  An OEM would be stupid to not take this product very seriously.  Especially when the Hospital test results are released.